These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10340136)

  • 1. [Agonists of the imidazoline receptors].
    Ol'binskaia LI; Bochenkov IuV
    Eksp Klin Farmakol; 1999; 62(2):68-72. PubMed ID: 10340136
    [No Abstract]   [Full Text] [Related]  

  • 2. [Imidazoline receptor agonists in the practical treatment of hypertension].
    Ol'binskaia LI; Bochenkov IuV; Alekseeva IL
    Ter Arkh; 1998; 70(2):86-8. PubMed ID: 9551585
    [No Abstract]   [Full Text] [Related]  

  • 3. Selective imidazoline receptor agonists for metabolic syndrome.
    Krentz AJ; Evans AJ
    Lancet; 1998 Jan; 351(9097):152-3. PubMed ID: 9449863
    [No Abstract]   [Full Text] [Related]  

  • 4. [The significance of the sympathetic nervous system during therapy for hypertension and related pathologies. Imidazoline-I1-receptor agonists. 17th Scientific Meeting of the International Society of Hypertension. Amsterdam, June 7, 1998].
    Dtsch Med Wochenschr; 1998 Aug; 123(33 Suppl):1-4. PubMed ID: 9739350
    [No Abstract]   [Full Text] [Related]  

  • 5. [Central nervous system as a target for the new antihypertensive agents].
    Nurminen ML
    Duodecim; 1999; 115(20):2267-73. PubMed ID: 11973931
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical pharmacology of hypotensive drugs acting on central imidazoline receptors].
    Drzewoski J; Wiśniewska-Jarosińska M
    Pol Arch Med Wewn; 1998 Dec; 100(6):561-9. PubMed ID: 10405570
    [No Abstract]   [Full Text] [Related]  

  • 7. [New trends in the treatment of arterial hypertension: identification of the I1 receptor and the pharmacology of imidazoline].
    Pavlović P
    Vojnosanit Pregl; 1998; 55(3):305-10. PubMed ID: 9720446
    [No Abstract]   [Full Text] [Related]  

  • 8. Selective stimulation of I1-imidazoline receptors as a novel mechanism for antihypertensive action. Focus on moxonidine.
    Papp JG; Ollivier JP
    J Cardiovasc Pharmacol; 1994; 24 Suppl 1():v-vi. PubMed ID: 7533220
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacology of moxonidine: an I1-imidazoline receptor agonist.
    Ernsberger P
    J Cardiovasc Pharmacol; 2000; 35(7 Suppl 4):S27-41. PubMed ID: 11346217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moxonidine: a review.
    Morris ST; Reid JL
    J Hum Hypertens; 1997 Oct; 11(10):629-35. PubMed ID: 9400904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective imidazoline receptor agonists and lipid metabolism.
    Elisaf M; Tselepis A; Siamopoulos K
    Clin Chem Lab Med; 1999 Feb; 37(2):165. PubMed ID: 10219506
    [No Abstract]   [Full Text] [Related]  

  • 12. I1 imidazoline agonists. General clinical pharmacology of imidazoline receptors: implications for the treatment of the elderly.
    Prichard BN; Graham BR
    Drugs Aging; 2000 Aug; 17(2):133-59. PubMed ID: 10984201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology and clinical use of moxonidine, a new centrally acting sympatholytic antihypertensive agent.
    Prichard BN; Owens CW; Graham BR
    J Hum Hypertens; 1997 Aug; 11 Suppl 1():S29-45. PubMed ID: 9321737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Angiotensin-II receptor blockers].
    Metelitsa VI
    Ter Arkh; 1996; 68(8):64-7. PubMed ID: 9019837
    [No Abstract]   [Full Text] [Related]  

  • 15. Imidazoline receptor agonist drugs: a new approach to the treatment of systemic hypertension.
    Yu A; Frishman WH
    J Clin Pharmacol; 1996 Feb; 36(2):98-111. PubMed ID: 8852385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-term antihypertensive therapy with moxonidine (cynt) in patients with insulin-independent diabetes mellitus].
    Lazebnik LB; Malichenko SB; Serebrov AN
    Ter Arkh; 1997; 69(6):59-64. PubMed ID: 9297279
    [No Abstract]   [Full Text] [Related]  

  • 17. [Imidazol receptor agonists--new possibilities for treating hypertension].
    Nowicki M; Wiecek A; Chudek J
    Postepy Hig Med Dosw; 1995; 49(5):631-43. PubMed ID: 8677226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Centrally acting imidazoline I1-receptor agonists: do they have a place in the management of hypertension?
    van Zwieten PA
    Am J Cardiovasc Drugs; 2001; 1(5):321-6. PubMed ID: 14728014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. I1 agents: a new approach to the treatment of hypertension.
    Dubar M; Pillion G
    Ann N Y Acad Sci; 1995 Jul; 763():642-58. PubMed ID: 7677384
    [No Abstract]   [Full Text] [Related]  

  • 20. [Efficacy of moxonidine, an imidazoline receptor agonist, in patients with essential hypertension].
    Baliakina EV; Patrusheva IF; Rynskova EE; Iurenev AP
    Ter Arkh; 1998; 70(1):15-9. PubMed ID: 9532644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.